Clinical Research Directory
Browse clinical research sites, groups, and studies.
Seizure Treatment in Glioma
Sponsor: Leiden University Medical Center
Summary
Currently, treatment with a specific anti-epileptic drug mainly depends on the physicians' preference, as there are no studies supporting the use of one specific anticonvulsant in glioma patients. The overall aim of this randomized controlled trial is to directly compare the effectiveness of treatment with levetiracetam or valproic acid in glioma patients with a first seizure.
Official title: Seizure Treatment in Glioma (STING): Comparing a Treatment Strategy with Levetiracetam Versus Treatment with Valproic Acid in Glioma Patients with a First Seizure
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2018-02-01
Completion Date
2028-07-01
Last Updated
2025-02-04
Healthy Volunteers
No
Conditions
Interventions
Levetiracetam
Antiepileptic drug levetiracetam
Valproic Acid
Antiepileptic drug valproic acid
Locations (5)
Amsterdam UMC
Amsterdam, Netherlands
Medisch Spectrum Twente
Enschede, Netherlands
Leiden University Medical Center
Leiden, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Haaglanden Medical Center
The Hague, Netherlands